Alerts will be sent to your verified email
Verify EmailFREDUN
|
Fredun Pharma
|
Shivalik Rasayan
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
8.53 % | 6.54 % | 7.31 % |
|
5yr average Equity Multiplier
|
3.02 | 1.82 | 1.48 |
|
5yr Average Asset Turnover Ratio
|
1.01 | 0.44 | 0.56 |
|
5yr Avg Net Profit Margin
|
2.89 % | 7.94 % | 8.44 % |
|
Price to Book
|
5.18 | 1.73 | 3.29 |
|
P/E
|
37.11 | 47.9 | 23.75 |
|
5yr Avg Cash Conversion Cycle
|
137.13 Days | 100.7 Days | 14.76 Days |
|
Inventory Days
|
146.68 Days | 80.64 Days | 14.42 Days |
|
Days Receivable
|
142.46 Days | 107.04 Days | 136.16 Days |
|
Days Payable
|
112.95 Days | 166.18 Days | 212.73 Days |
|
5yr Average Interest Coverage Ratio
|
2.62 | 8.55 | 6.02 |
|
5yr Avg ROCE
|
16.75 % | 8.54 % | 11.26 % |
|
5yr Avg Operating Profit Margin
|
8.32 % | 17.6 % | 12.28 % |
|
5 yr average Debt to Equity
|
0.86 | 0.2 | 0.17 |
|
5yr CAGR Net Profit
|
25.5 % | -1.04 % | 48.72 % |
|
5yr Average Return on Assets
|
3.05 % | 3.57 % | 4.99 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
48.93 % | 47.37 % | 63.77 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.11 % | -2.95 % | -4.48 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Fredun Pharma
|
Shivalik Rasayan
|
Kilitch Drugs(India)
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|